SEL-313

N/A

Report date: 2023/10/26 16:55:58

Base Information

Drug NameSEL-313
Drug Alias NameSEL-313
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionOTC gene transference
TargetsOrnithine carbamoyltransferase
Therapy Area/IndicationsUrea Cycle Disorders, Inborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSelecta Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesSelecta Biosciences Inc
Inactive CompaniesN/A
Active IndicationsUrea Cycle Disorders, Inborn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A